Violation Tracker Individual Record

Company: 
Cell Therapeutics Inc.
Penalty: 
$10,500,000
Year: 
2007
Date: 
April 17, 2007
Offense Group: 
healthcare-related offenses
Primary Offense: 
off-label or unapproved promotion of medical products
Secondary Offense: 
kickbacks and bribery
Violation Description: 

Cell Therapeutics Inc. has agreed to pay the United States $10.5 million to resolve allegations of the company's improper marketing of the anti-cancer prescription drug Trisenox. According to the government's complaint, CTI promoted the drug for various uses that were unapproved by the Food & Drug Administration.

Level of Government: 
federal
Action Type: 
agency action
Agency: 
Justice Department Civil Division
Civil or Criminal Case: 
civil
Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.